EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Association between prescribed antidepressant medication and skin cancer (melanoma, basal cell carcinoma and cutaneous squamous cell carcinoma) risk: a systematic review and meta-analysis

Tabassum Rahman, Mikolaj Swiderski iD, Zoe C Venables iD, Zenas Z N Yiu iD, Lesley E Rhodes iD, Neil Nixon iD, Sonia Gran iD

Skin Health and Disease · 29.05.2026 · 6 (3) · 232-241

DOI: 10.1093/skinhd/vzag028 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Skin Health and Disease, online erschienen am 17.04.2026. Verfasst von Tabassum Rahman und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Nottingham, Nottingham, UK. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR Manchester Biomedical Research Centre.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Certain antidepressants act as photosensitizers and may affect skin cancer risk; however, no evidence synthesis has been conducted. With the rising global incidence of skin cancer and widespread antidepressant use, clarifying any potential association is essential for public health.

Objectives

To assess the association between prescribed antidepressants and skin cancer (basal cell carcinoma, cutaneous squamous cell carcinoma and melanoma) risk.

Methods

The protocol was registered on PROSPERO. MEDLINE and Embase were searched on 5 October 2025. Titles, abstracts and full texts were screened, and the methodologies appraised by two independent reviewers. The Mantel–Haenszel method (random-effects model) was applied to pool odds ratios (ORs), and the inverse variance method was used for rate ratios (RRs); heterogeneity was assessed using I2. The GRADE (Grading of Recommendations Assessment, Development, and Evaluation) framework assessed the certainty of evidence. Subgroup analyses included a comparison of skin cancer risk between selective serotonin reuptake inhibitors (SSRIs) and non-SSRIs.

Results

Ten studies were included, five of which contributed to the meta-analysis. The association between antidepressant use and skin cancer risk was not statistically significant [RR 0.83, 95% confidence interval (CI) 0.60–1.16 (P = 0.28, I2 = 87%); OR 0.93, 95% CI 0.85–1.02 (P = 0.12, I2 = 69%)]. The subgroup analysis results for those who did and did not use SSRIs were similar and showed no statistically significant associations with skin cancer risk. The certainty of evidence was very low.

Conclusions

No statistically significant association was found between antidepressant use and skin cancer risk. Further high-quality research considering important confounders such as skin type, skin cancer type, sun exposure-related behaviour and sufficient follow-up is needed to confirm these findings.

Autor:innen und Institutionen

  • School of Medicine, University of Nottingham, Nottingham, UK.
  • Centre of Evidence Based Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.
  • Department of Dermatology, Norfolk and Norwich University Hospital, Norwich, UK.
  • Norwich Medical School, University of East Anglia, Norwich, UK.
  • Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, NIHR Manchester Biomedical Research Centre, University of Manchester, Manchester, UK.
  • Department of Dermatology, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

ORCID-Profile: Mikolaj Swiderski, Zoe C Venables, Zenas Z N Yiu, Lesley E Rhodes, Neil Nixon, Sonia Gran

Förderung

  • NIHR Manchester Biomedical Research Centre

Zitieren

APA

Rahman, T., Swiderski, M., Venables, Z. C., Yiu, Z. Z. N., Rhodes, L. E., Nixon, N., & Gran, S. (2026). Association between prescribed antidepressant medication and skin cancer (melanoma, basal cell carcinoma and cutaneous squamous cell carcinoma) risk: a systematic review and meta-analysis. Skin Health and Disease, 6(3), 232-241. https://doi.org/10.1093/skinhd/vzag028

Vancouver

Rahman T, Swiderski M, Venables ZC, Yiu ZZN, Rhodes LE, Nixon N, et al. Association between prescribed antidepressant medication and skin cancer (melanoma, basal cell carcinoma and cutaneous squamous cell carcinoma) risk: a systematic review and meta-analysis. Skin Health and Disease. 2026;6(3):232-241. doi:10.1093/skinhd/vzag028

BibTeX
@article{Rahman2026,
  author = {Rahman, Tabassum and Swiderski, Mikolaj and Venables, Zoe C and Yiu, Zenas Z N and Rhodes, Lesley E and Nixon, Neil and Gran, Sonia},
  title = {Association between prescribed antidepressant medication and skin cancer (melanoma, basal cell carcinoma and cutaneous squamous cell carcinoma) risk: a systematic review and meta-analysis},
  journal = {Skin Health and Disease},
  year = {2026},
  volume = {6},
  number = {3},
  pages = {232--241},
  doi = {10.1093/skinhd/vzag028}
}
Kostenlos starten →